Coherus Oncology (CHRS) Return on Assets (2014 - 2026)
Coherus Oncology (CHRS) posted Return on Assets of 0.01% for Q1 2026, up 51.05% sequentially from 0.01% in Q4 2025, and up 1.0% YoY from 0.01% in Q1 2025.
Coherus Oncology (CHRS) Return on Assets (2014 - 2026) Analysis & Trends
Coherus Oncology has reported Return on Assets for 13 years, with the latest figure at 0.01% in Q1 2026.
- Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
- Return on Assets improved to 0.01% in Q1 2026 per CHRS's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q1 2026 and troughed at 0.01% in Q1 2023.
- A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2022 and 2024: Return on Assets changed 0 bps in 2022, then rose 1 bps in 2024.
- Over 5 years, Return on Assets stood at 0.01% in 2022, then soared by 31 bps to 0.0% in 2023, then soared by 231 bps to 0.01% in 2024, then surged by 76 bps to 0.01% in 2025, then jumped by 51 bps to 0.01% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Coherus Oncology | 203.82 Mn | 98.51 Mn | 10.07 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |